Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
THAR	THARIMMUNE INC	$1.73	16.89%	43.57%	27.21%	-12.63%	-49.56%	-68.23%	-99.62%	N/A	N/A	$6.45	$0.95	73.17%	81.72%	0.73	529,429	81.47%
XTLB	XTL BIOPHARMACEUTICALS LTD	$1.41	7.63%	16.05%	17.99%	-10.19%	-20.79%	-45.56%	-35.02%	16.14%	-87.12%	$3.15	$0.92	55.24%	53.09%	0.68	88,816	5,231.09%
IMNN	IMUNON INC	$0.84	-4.65%	-4.22%	-20.00%	-7.69%	-12.50%	-35.88%	-72.64%	-95.76%	-99.85%	$3.65	$0.64	76.99%	31.25%	0.85	85,217	74.70%
SPRO	SPERO THERAPEUTICS INC	$0.66	-1.94%	-9.49%	-8.61%	-24.37%	-48.99%	-53.66%	-87.07%	-94.71%	N/A	$1.72	$0.51	61.74%	30.30%	0.81	79,293	51.50%
TCRT	ALAUNOS THERAPEUTICS INC	$2.45	2.94%	-0.41%	66.67%	47.15%	21.29%	-80.56%	-96.68%	-99.42%	-99.81%	$14.20	$1.31	82.75%	86.45%	1.19	12,882	21.52%
TENX	TENAX THERAPEUTICS INC	$5.76	1.68%	5.49%	-12.06%	-4.00%	33.95%	47.69%	-99.47%	-99.45%	-99.99%	$7.89	$2.77	27.00%	107.94%	0.48	14,050	88.36%
TSBX	TURNSTONE BIOLOGICS CORP	$0.37	7.99%	15.51%	-10.98%	-24.59%	-23.16%	-85.96%	N/A	N/A	N/A	$3.39	$0.29	89.23%	25.86%	1.20	27,491	834.75%
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$0.42	-9.79%	-18.62%	-27.27%	-96.41%	-96.29%	-96.20%	-95.77%	N/A	N/A	$15.80	$0.40	97.32%	5.74%	0.53	275,842	14.86%
VANI	VIVANI MEDICAL INC	$1.03	0.00%	0.00%	-1.90%	-11.97%	-23.13%	-36.42%	-79.19%	-74.19%	-99.63%	$2.09	$0.91	50.72%	13.81%	1.16	20,827	-53.81%
KZIA	KAZIA THERAPEUTICS LTD	$3.59	3.46%	7.97%	-8.28%	-62.21%	-87.36%	-78.55%	-98.86%	-97.55%	-99.68%	$79.00	$2.86	95.46%	25.52%	0.97	66,771	605.23%
OKYO	OKYO PHARMA LTD	$1.59	0.00%	5.67%	24.80%	44.09%	36.05%	5.67%	N/A	N/A	N/A	$1.74	$0.81	8.91%	96.41%	0.52	39,622	71.43%
PALI	PALISADE BIO INC	$0.78	2.65%	9.60%	13.95%	-45.73%	-74.97%	-87.13%	-99.86%	-99.98%	-100.00%	$8.57	$0.60	90.95%	29.33%	1.07	76,055	212.32%
SNGX	SOLIGENIX INC	$1.97	-0.51%	-4.83%	-8.37%	-14.72%	-47.18%	-68.43%	-98.50%	-99.47%	-99.95%	$14.83	$1.68	86.72%	17.26%	0.45	7,814	-86.10%
SYBX	SYNLOGIC INC	$1.14	-0.87%	-1.21%	-8.06%	-18.28%	-21.92%	-36.31%	-95.45%	-96.35%	N/A	$1.91	$0.90	40.31%	26.95%	0.87	3,953	4.91%
PYPD	POLYPID LTD	$2.85	8.78%	3.64%	5.17%	-4.68%	-19.49%	-40.28%	-98.12%	N/A	N/A	$4.98	$2.30	42.77%	23.91%	0.66	70,408	111.16%
KLTO	KLOTHO NEUROSCIENCES INC	$0.17	-2.94%	9.27%	-27.63%	-58.33%	-67.65%	-97.77%	-98.33%	N/A	N/A	$11.05	$0.11	98.51%	44.74%	0.48	50,653	-28.37%
SER	SERINA THERAPEUTICS INC	$6.31	9.17%	9.17%	11.29%	37.17%	-6.66%	-29.10%	-79.28%	-78.75%	N/A	$14.57	$3.81	56.69%	65.62%	0.35	18,607	4,288.44%
OVID	OVID THERAPEUTICS INC	$0.33	-3.25%	0.62%	4.81%	-53.29%	-71.57%	-89.28%	-88.72%	-91.02%	N/A	$3.43	$0.24	90.46%	35.12%	0.84	458,322	21.72%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$2.64	3.45%	9.01%	-2.08%	-25.06%	-25.90%	-42.03%	-98.12%	-99.80%	N/A	$8.92	$1.90	70.43%	38.84%	0.84	118,575	137.09%
SABS	SAB BIOTHERAPEUTICS INC	$1.70	2.72%	24.09%	25.00%	-21.66%	-45.34%	-60.37%	-92.92%	N/A	N/A	$5.01	$1.00	66.07%	70.00%	0.67	17,633	52.03%
PHAR	PHARMING GROUP NV	$8.78	3.11%	6.11%	4.89%	-0.28%	-0.96%	-10.18%	8.20%	N/A	N/A	$11.07	$6.65	20.73%	31.95%	0.50	2,156	681.16%
RNAZ	TRANSCODE THERAPEUTICS INC	$0.41	-5.79%	29.62%	-17.78%	-94.94%	-97.55%	-97.97%	-100.00%	N/A	N/A	$66.33	$0.22	99.39%	85.00%	1.32	1,641,667	44.30%
TNYA	TENAYA THERAPEUTICS INC	$0.48	-1.66%	5.09%	-16.67%	-55.19%	-76.83%	-89.54%	-95.01%	N/A	N/A	$4.96	$0.39	90.42%	20.56%	1.80	1,701,738	6.71%
TOVX	THERIVA BIOLOGICS INC	$1.35	-4.53%	-5.59%	22.73%	5.47%	-8.78%	-86.58%	-97.77%	-98.45%	-99.99%	$12.28	$0.96	89.00%	41.21%	0.83	27,087	592.76%
PHGE	BIOMX INC	$0.61	-2.09%	3.05%	9.53%	-13.74%	-23.88%	-87.29%	-95.55%	-98.98%	N/A	$4.90	$0.48	87.57%	27.67%	0.43	37,605	79.79%
TTNP	TITAN PHARMACEUTICALS INC	$3.73	3.90%	0.81%	5.67%	9.71%	-7.90%	-44.37%	-73.29%	-97.60%	-99.97%	$14.80	$3.03	74.80%	23.10%	0.40	728	-86.06%
RLMD	RELMADA THERAPEUTICS INC	$0.32	13.38%	-53.33%	19.26%	-9.04%	-90.80%	-91.15%	-98.76%	-99.23%	N/A	$4.47	$0.24	92.80%	34.17%	0.69	2,292,082	-51.20%
NBTX	NANOBIOTIX SA	$3.39	7.65%	2.91%	-5.31%	-4.51%	-22.43%	-41.95%	-42.54%	N/A	N/A	$7.51	$2.76	54.86%	22.83%	0.95	22,400	622.35%
RNXT	RENOVORX INC	$0.96	-1.03%	-2.04%	-3.03%	-28.84%	-4.00%	-20.66%	-41.10%	N/A	N/A	$1.69	$0.75	43.20%	28.00%	0.87	71,057	14.90%
RENB	RENOVARO INC	$0.36	6.51%	-4.26%	-33.70%	-52.94%	-33.33%	-77.22%	-95.59%	-89.47%	N/A	$2.34	$0.30	84.62%	18.42%	1.13	816,446	2.21%
AEON	AEON BIOPHARMA INC	$0.43	5.61%	-1.59%	-25.34%	-95.05%	-99.35%	-99.84%	-99.94%	N/A	N/A	$269.28	$0.38	99.84%	15.47%	0.11	204,892	58.12%
PTN	PALATIN TECHNOLOGIES INC	$0.17	-60.90%	-67.71%	-78.46%	-85.14%	-81.25%	-91.75%	-98.55%	-98.56%	-99.33%	$2.48	$0.16	93.35%	2.48%	1.19	6,504,308	535.06%
PMN	PROMIS NEUROSCIENCES INC	$0.62	6.35%	4.20%	-10.92%	-30.34%	-43.12%	-69.05%	N/A	N/A	N/A	$2.37	$0.51	73.84%	21.33%	0.35	12,203	-51.20%
QLGN	QUALIGEN THERAPEUTICS INC	$3.58	2.87%	-7.01%	-1.65%	5.14%	-30.42%	-76.12%	-98.70%	-99.91%	N/A	$29.44	$2.85	87.84%	25.61%	0.70	14,271	198.87%
PTIX	PROTAGENIC THERAPEUTICS INC	$0.22	2.75%	-1.32%	14.87%	-41.36%	-65.80%	-83.73%	-93.06%	-95.52%	-99.64%	$1.87	$0.18	88.02%	25.14%	-0.16	693,417	8.00%
PRTC	PURETECH HEALTH PLC	$17.26	-1.37%	0.70%	-12.74%	-7.00%	-17.18%	-38.11%	-13.84%	N/A	N/A	$32.98	$13.30	47.67%	29.77%	0.50	1,114	-71.97%
PMCB	PHARMACYTE BIOTECH INC	$1.24	0.00%	4.20%	-0.80%	-23.46%	-33.69%	-41.51%	-45.85%	-96.73%	-99.48%	$2.42	$1.03	48.82%	20.39%	0.44	2,797	-76.07%
PASG	PASSAGE BIO INC	$0.33	4.49%	-2.98%	-7.65%	-44.27%	-47.76%	-74.73%	-83.02%	-98.03%	N/A	$1.64	$0.30	80.12%	8.67%	1.40	213,029	154.16%
QNCX	QUINCE THERAPEUTICS INC	$1.10	-2.65%	3.77%	-17.29%	-31.25%	-16.03%	2.80%	-71.65%	-97.59%	N/A	$2.45	$0.51	55.10%	114.84%	0.71	78,034	78.38%
OGEN	ORAGENICS INC	$0.19	-3.13%	-4.12%	-11.43%	-39.41%	-41.88%	-82.03%	-99.04%	-99.28%	-99.96%	$3.43	$0.16	94.58%	14.81%	0.87	111,451	-21.63%
VRCA	VERRICA PHARMACEUTICALS INC	$0.46	0.87%	1.09%	4.98%	-35.29%	-71.00%	-93.34%	-92.97%	-96.16%	N/A	$11.41	$0.38	95.93%	21.47%	0.92	119,749	-16.24%
RNTX	REIN THERAPEUTICS INC	$1.71	-3.93%	-8.06%	-3.39%	-13.64%	-55.58%	-62.42%	-79.80%	-84.33%	N/A	$4.40	$1.35	61.14%	26.67%	1.02	33,527	43.47%
PLRZ	POLYRIZON LTD	$0.31	0.98%	-6.06%	-15.99%	-76.52%	-81.55%	N/A	N/A	N/A	N/A	$4.80	$0.28	93.54%	10.32%	-1.20	138,841	-61.21%
NRXS	NEURAXIS INC	$2.35	5.86%	-2.77%	9.30%	-13.28%	-10.65%	-26.56%	N/A	N/A	N/A	$3.78	$1.33	37.83%	76.69%	0.92	26,938	371.11%
NLSP	NLS PHARMACEUTICS LTD	$1.47	-3.48%	0.14%	-4.42%	-25.66%	-61.87%	-73.66%	-95.22%	N/A	N/A	$18.39	$1.30	91.99%	13.23%	0.36	4,841	-93.76%
TNFA	TNF PHARMACEUTICALS INC	$0.19	-0.52%	2.13%	-45.14%	-78.40%	-86.82%	-93.77%	-99.83%	-99.91%	-100.00%	$3.37	$0.16	94.30%	18.52%	1.00	855,038	-65.63%
NERV	MINERVA NEUROSCIENCES INC	$1.67	-3.19%	-6.18%	-1.76%	-29.83%	-31.28%	-29.24%	-58.24%	-97.67%	-95.88%	$3.69	$1.15	54.74%	45.22%	0.51	18,700	33.12%
NCNA	NUCANA PLC	$0.59	11.32%	-33.71%	-32.42%	-42.72%	-65.90%	-85.10%	-96.63%	-99.58%	N/A	$10.79	$0.52	94.53%	13.46%	0.95	373,125	8.64%
MTVA	METAVIA INC	$0.76	-2.44%	-6.40%	-50.58%	-59.52%	-71.28%	-76.58%	-99.49%	-99.98%	N/A	$5.30	$0.65	85.64%	17.62%	0.46	73,270	-18.53%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$9.11	-2.46%	16.50%	69.33%	106.11%	N/A	N/A	N/A	N/A	N/A	$14.30	$3.50	36.29%	160.29%	1.35	406,536	-73.25%
MRSN	MERSANA THERAPEUTICS INC	$0.43	17.34%	11.03%	25.87%	-32.03%	-76.84%	-86.34%	-88.30%	-95.20%	N/A	$3.63	$0.26	88.07%	67.18%	1.63	3,262,462	43.84%
PCSA	PROCESSA PHARMACEUTICALS INC	$0.26	12.66%	7.95%	-30.27%	-60.61%	-80.60%	-88.17%	-99.52%	-99.83%	-99.97%	$3.10	$0.15	91.68%	72.00%	0.76	8,182,018	1,283.12%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$0.59	-8.23%	1.03%	13.65%	0.17%	-69.38%	-93.63%	-98.39%	-98.46%	N/A	$9.60	$0.48	93.84%	24.42%	1.01	53,164	252.34%
NXTC	NEXTCURE INC	$0.47	-5.68%	10.71%	-3.13%	-41.80%	-65.56%	-61.57%	-88.63%	-98.57%	N/A	$1.82	$0.22	74.45%	107.59%	0.90	245,968	44.76%
MLEC	MOOLEC SCIENCE SA	$0.74	2.78%	20.33%	32.14%	-1.33%	-13.95%	-47.89%	-92.56%	N/A	N/A	$1.45	$0.53	48.97%	39.62%	0.38	37,705	-20.66%
LYRA	LYRA THERAPEUTICS INC	$0.12	0.85%	27.96%	-5.56%	-34.97%	-56.41%	-97.69%	-97.98%	-99.36%	N/A	$5.26	$0.08	97.74%	45.12%	0.45	2,263,807	-74.35%
SPRB	SPRUCE BIOSCIENCES INC	$0.08	5.06%	-36.15%	-71.38%	-77.51%	-85.93%	-88.31%	-95.28%	N/A	N/A	$0.87	$0.06	90.46%	45.61%	1.14	4,396,493	-66.56%
MEIP	MEI PHARMA INC	$2.04	2.00%	3.03%	-6.85%	-27.14%	-34.41%	-33.11%	-81.41%	-96.24%	-94.87%	$4.10	$1.46	50.24%	39.73%	0.71	8,299	-29.97%
LPTX	LEAP THERAPEUTICS INC	$0.42	8.01%	5.82%	37.05%	-19.46%	-89.98%	-86.52%	-96.95%	-98.09%	N/A	$4.79	$0.22	91.27%	88.29%	1.22	1,487,422	500.61%
LPCN	LIPOCINE INC	$3.31	1.53%	6.77%	4.09%	-25.95%	-38.93%	-28.35%	-78.30%	-64.84%	-97.07%	$11.79	$2.75	71.93%	20.36%	0.90	9,270	24.76%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$1.26	-2.02%	-3.08%	4.13%	-49.19%	-40.85%	-54.35%	-90.87%	-85.84%	-37.00%	$3.50	$1.02	64.00%	23.53%	0.30	2,615	-66.67%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.